The disclosure concerns indolin-2-one pyridine compounds of general formula (I):
wherein R
0
, R
1
, R
2
, R
3
, R
4
, Z and B have the meanings given in the description, and pharmaceutically acceptable salts thereof; and also pharmaceutical compositions comprising, processes for making and methods of using said compounds.
该披露涉及一般式(I)的
吲哚啉-2-酮
吡啶化合物:其中R0,R1,R2,R3,R4,Z和B具有所述描述中给出的含义,以及其药学上可接受的盐;还包括含有该化合物的制药组合物,制备该化合物的方法以及使用该化合物的方法。